• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

165.35 -0.33 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Avoid
March 18, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
March 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗
March 15, 2026
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships. 
Via The Motley Fool
Discover the top S&P500 movers in Thursday's after-hours session. ↗
March 12, 2026
Via Chartmill
Insulet Corp (NASDAQ:PODD): A High-Growth Stock Forming a Technical Base ↗
February 25, 2026
Via Chartmill
Insulet Corp. (NASDAQ:PODD) Reports Strong Q4 Earnings Beat Amid Mixed 2026 Guidance ↗
February 18, 2026
Via Chartmill
Topics Earnings
News headline image
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗
March 15, 2026
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America ↗
March 14, 2026
-link data-ticker=GOOGL data-exchange=NASDAQ href=https://www.benzinga.com/quote/GOOGL target=_blank rel=noopener>(NASDAQ: GOOGL), One week after we celebrated the International Women's day, here is a... 
Via Benzinga
Topics ETFs Stocks
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
March 13, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 13, 2026
From Law Offices of Howard G. Smith
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
March 13, 2026
Via Chartmill
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
March 13, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
Friday's session: top gainers and losers in the S&P500 index ↗
March 13, 2026
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
March 13, 2026
Via Chartmill
Top S&P500 movers in Friday's pre-market session ↗
March 13, 2026
Via Chartmill
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
March 12, 2026
From Insulet Corporation, Inc.
Via Business Wire
News headline image
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
March 11, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 10, 2026
From Insulet Corporation
Via Business Wire
News headline image
1 Oversold Stock Set for a Comeback and 2 Facing Challenges
February 26, 2026
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
February 20, 2026
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
February 20, 2026
Via Chartmill
Which S&P500 stocks are moving on Thursday? ↗
February 19, 2026
Via Chartmill
News headline image
PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance
February 19, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 31.2% year on year to $783.8 million. The company... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
February 18, 2026
Via Chartmill
News headline image
Insulet (PODD) Shares Skyrocket, What You Need To Know
February 18, 2026
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 5.6% in the afternoon session after the company posted strong fourth-quarter 2025 financial results that beat Wall Street's... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
February 18, 2026
Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings... 
Via MarketMinute
Topics Earnings
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
February 18, 2026
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
February 18, 2026
Via Chartmill
News headline image
Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales
February 18, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 31.2% year on year to $783.8 million. The company expects... 
Via StockStory
News headline image
Insulet Reports Fourth Quarter and Full Year 2025 Results
February 18, 2026
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap